Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

Game-changing obesity drugs go mainstream: what scientists are learning

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 618, 17-18 (2023)

doi: https://doi.org/10.1038/d41586-023-01712-8

References

  1. Wilding, J. P. H. et al. N. Engl. J. Med. 384, 989–1002 (2021).

    Article  PubMed  Google Scholar 

  2. Jastreboff, A. M. et al. N. Engl. J. Med. 387, 205–216 (2022).

    Article  PubMed  Google Scholar 

  3. Acosta, A. et al. Obesity 29, 662–671 (2021).

    Article  PubMed  Google Scholar 

  4. Jensterle, M. et al. Endocr. Abstr. 81, OC5.2 (2022).

    Article  Google Scholar 

  5. Rubino, D. et al. JAMA 325, 1414–1425 (2021).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links